Evaluating Social Media Networks in Medicines Safety Surveillance: Two Case Studies

Por Coloma, Preciosa M., Becker, Benedikt, Sturkenboom, Miriam C. J. M., van Mulligen, Erik M., Kors, Jan A.
Publicado no Drug Saf (2015)

Obtaining research biopsies during pediatric colonoscopy: Safety and adverse events

Por Mait-Kaufman, Jennifer, Kahn, Stacie, Tomer, Gitit
Publicado no World J Gastrointest Endosc (2015)

Warfarin-associated bleeding events and concomitant use of potentially interacting medicines reported to the Norwegian spontaneous reporting system

Por Narum, Sigrid, Solhaug, Vigdis, Myhr, Kirsten, Johansen, Per Wiik, Brørs, Odd, Kringen, Marianne Kristiansen
Publicado em 2011

Safety of Adalimumab and Predictors of Adverse Events in 1693 Japanese Patients with Crohn’s Disease

Por Ogata, Haruhiko, Watanabe, Mamoru, Matsui, Toshiyuki, Hase, Hidenori, Okayasu, Motohiro, Tsuchiya, Tsuyoshi, Shinmura, Yasuhiko, Hibi, Toshifumi
Publicado no J Crohns Colitis (2016)

Liver injury with novel oral anticoagulants: assessing post-marketing reports in the US Food and Drug Administration adverse event reporting system

Por Raschi, Emanuel, Poluzzi, Elisabetta, Koci, Ariola, Salvo, Francesco, Pariente, Antoine, Biselli, Maurizio, Moretti, Ugo, Moore, Nicholas, De Ponti, Fabrizio
Publicado no Br J Clin Pharmacol (2015)

Quality and safety in transitional care of the elderly: the study protocol of a case study research design (phase 1)

Por Aase, Karina, Laugaland, Kristin Alstveit, Dyrstad, Dagrunn Nåden, Storm, Marianne
Publicado em 2013

Estimating the incidence of adverse events in Portuguese hospitals: a contribution to improving quality and patient safety

Por Sousa, Paulo, Uva, António Sousa, Serranheira, Florentino, Nunes, Carla, Leite, Ema S
Publicado em 2014

The efficacy and safety of apatinib in metastatic alveolar soft part sarcoma: a case series of six patients in one institution

Por Wang Y, Min L, Zhou Y, Tang F, Luo Y, Zhang W, Duan H, Tu C
Publicado em 2019-04-01

The efficacy and safety of apatinib in metastatic alveolar soft part sarcoma: a case series of six patients in one institution

Por Wang, Yitian, Min, Li, Zhou, Yong, Tang, Fan, Luo, Yi, Zhang, Wenli, Duan, Hong, Tu, Chongqi
Publicado no Cancer Manag Res (2019)

Assessment of knowledge and attitudes towards safety events reporting among residents in a community health system

Por Singal, M., Zafar, A., Tbakhi, B., Jadhav, N., Alweis, R., Bhavsar, H.
Publicado no J Community Hosp Intern Med Perspect (2018)

Improving drug safety in hospitals: a retrospective study on the potential of adverse drug events coded in routine data

Por Kuklik, Nils, Stausberg, Jürgen, Amiri, Marjan, Jöckel, Karl-Heinz
Publicado no BMC Health Serv Res (2019)

Combination therapy with once-weekly glucagon like peptide-1 receptor agonists and dipeptidyl peptidase-4 inhibitors in type 2 diabetes: a case series

Por Estela Lajthia, John D. Bucheit, Pramit A. Nadpara, Dave L. Dixon, Lauren M. Caldas, Michael Murchie, Evan M. Sisson
Publicado no Pharmacy Practice (2019)

Combination therapy with once-weekly glucagon like peptide-1 receptor agonists and dipeptidyl peptidase-4 inhibitors in type 2 diabetes: a case series

Por Lajthia, Estela, Bucheit, John D., Nadpara, Pramit A., Dixon, Dave L., Caldas, Lauren M., Murchie, Michael, Sisson, Evan M.
Publicado no Pharm Pract (Granada) (2019)

The most frequent and important events that threaten patient safety in intensive care units from the perspective of health-care professionals'

Por Sedigheh Farzi, Mahmoud Saghaei, Alireza Irajpour, Hamid Ravaghi
Publicado em 2018-01-01

The most frequent and important events that threaten patient safety in intensive care units from the perspective of health-care professionals'

Por Farzi, Sedigheh, Saghaei, Mahmoud, Irajpour, Alireza, Ravaghi, Hamid
Publicado no J Res Med Sci (2018)

1380. Safety of Repurposed Drugs for Multidrug-Resistant and Extensively Drug-Resistant Tuberculosis: An Analysis of Adverse Events Reported in the Literature

Por Stone, Heather, Duggal, Mili, Sacks, Leonard, Ghosh, Mayurika
Publicado no Open Forum Infect Dis (2019)

The relationship and interinfluence of aspects of therapy safety and compliance in patients...

Por Yu. V. Lukina, N. A. Dmitrieva, N. P. Kutishenko, N. V. Kiseleva, S. Yu. Martsevich
Publicado em 2018-10-01

Safety and rate of delayed adverse events with lumen-apposing metal stents (LAMS) for pancreatic fluid collections: a multicenter study

Por Yang, Dennis, Perbtani, Yaseen B., Mramba, Lazarus K, Kerdsirichairat, Tossapol, Prabhu, Anoop, Manvar, Amar, Ho, Sammy, Pannu, Davindebir, Keswani, Rajesh N., Strand, Daniel S., Wang, Andrew Y., Quintero, Eduardo, Buscaglia, Jonathan M., Muniraj, Thiruvengadam, Aslanian, Harry R., Draganov, Peter V., Siddiqui, Ali S.
Publicado no Endosc Int Open (2018)

Safety and tolerability of Meningococcus B vaccine in patients with chronical medical conditions (CMC)

Por L. Nicolosi, C. Rizzo, G. Castelli Gattinara, N. Mirante, E. Bellelli, C. Bianchini, V. Pansini, A. Villani
Publicado em 2019-10-01

Patient safety incident reports related to traditional Japanese Kampo medicines: medication errors...

Por Shimada, Yutaka, Fujimoto, Makoto, Nogami, Tatsuya, Watari, Hidetoshi, Kitahara, Hideyuki, Misawa, Hiroki, Kimbara, Yoshiyuki
Publicado no BMC Complement Altern Med (2017)